A method of preventing the development of dyskinesias in patients being treated for Parkinson's Disease requires the administration of a pharmacologically effective amount of a substituted phenylazacycloalkane to the patient. The patient is treated for Parkinson's disease by administering at least one dopamine agonist to the patient and by the transplantation of dopamine neurons into the patient's brain.
Method of treating Parkinson's disease